21 CFR § 333.280 Topical Antimicrobial Drug Products for Over-the-Counter Human Use

§ 333.280 Professional labeling.

Current through Sep 8, 2026 · Read all of Part 333

The labeling provided to health professionals (but not to the general public) may contain the following additional indication:

(a) For products containing haloprogin or miconazole nitrate identified in § 333.210 (a) and (c). “For the treatment of superficial skin infections caused by yeast (Candida albicans).”

(b) [Reserved]

← § 333.250 Labeling of antifungal drug products.§ 333.301 Scope. →